News

FDA approves durvalumab for resectable gastric or gastroesophageal junction adenocarcinoma

New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications

Potential treatment to bypass resistance in deadly childhood cancer

Researchers identify why some lung tumours respond well to immunotherapy

AI tops density in predicting breast cancer risk

High risk of metastatic recurrence among young cancer patients - Research highlights urgent need for tailored survivorship care

Study identifies target for disease hyper progression after immunotherapy in kidney cancer

Scientists develop one-product-fits-all immunotherapy for pancreatic cancer

Study suggests many men may not need long-term hormone therapy for prostate cancer

HER2-targeted therapy shows promising results in rare bile duct cancers

Liquid biopsy tool to guide early-stage gastric cancer treatment

Much-needed new drug approved for deadliest blood cancer